Mercado de tratamiento del mieloma múltiple: análisis y pronóstico de la industria global 2017 – 2025
Introducción:
El mieloma múltiple, también conocido como mieloma de células plasmáticas, es un tipo de cáncer de la sangre que afecta a las células plasmáticas de la médula ósea. Se espera que el mercado del tratamiento del mieloma múltiple crezca significativamente en los próximos años, impulsado por factores como la creciente prevalencia de la enfermedad, la creciente demanda de tratamientos efectivos y la introducción de nuevas terapias.
Visión general del mercado:
El mieloma múltiple es un cáncer formado por células plasmáticas malignas. Las células plasmáticas normales se encuentran en la médula ósea y son una parte importante del sistema inmunitario. Las células plasmáticas ayudan a combatir las infecciones al producir anticuerpos que reconocen y atacan los gérmenes.
Obtenga una muestra gratuita en PDF de este informe aquí:
https://www.persistencemarketresearch.com/samples/13954
Por tipo de terapia, el mercado está segmentado en quimioterapia, terapia dirigida, inmunoterapia, trasplante de células madre y otros. El segmento de terapias dirigidas representó la mayor parte del mercado en 2020, impulsado por la creciente adopción de terapias dirigidas, como los inhibidores del proteasoma y los fármacos inmunomoduladores.
Por tipo de fármaco, el mercado está segmentado en inhibidores del proteasoma, fármacos inmunomoduladores, anticuerpos monoclonales y otros. El segmento de inhibidores de proteasoma representó la mayor parte del mercado en 2020, impulsado por la alta eficacia de los inhibidores de proteasoma como bortezomib y carfilzomib en el tratamiento del mieloma múltiple.
By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies accounted for the largest share of the market in 2020, driven by the high usage of hospital pharmacies for the distribution of multiple myeloma drugs.
Regional Analysis:
North America accounted for the largest share of the multiple myeloma treatment market in 2020, followed by Europe and Asia Pacific. The market in North America is driven by factors such as the increasing prevalence of multiple myeloma, the growing demand for effective treatments, and the presence of major market players. The Asia Pacific market is expected to witness the highest growth during the forecast period, driven by factors such as the increasing awareness about multiple myeloma, the growing healthcare expenditure, and the introduction of new therapies.
Key Players:
The multiple myeloma treatment market is highly competitive, with the presence of several major players. Some of the key players in the market include Johnson & Johnson, Bristol-Myers Squibb Company, Amgen Inc., Novartis International AG, and Takeda Pharmaceutical Company Limited. These companies are focusing on product innovation, strategic collaborations, and acquisitions to strengthen their market position.
Conclusion:
The multiple myeloma treatment market is expected to witness significant growth during the forecast period, driven by factors such as the increasing prevalence of the disease, the growing demand for effective treatments, and the introduction of new therapies. The market is highly competitive, with the presence of several major players. Companies are focusing on product innovation, strategic collaborations, and acquisitions to strengthen their market position. North America accounted for the largest share of the market in 2020, while the Asia Pacific market is expected to witness the highest growth during the forecast period. With the increasing awareness about multiple myeloma and the growing healthcare expenditure, the multiple myeloma treatment market is poised for significant growth in the coming years.
You Can Pre-Book this Report as per Your Interest Click Here:
https://www.persistencemarketresearch.com/checkout/13954
About Persistence Market Research:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
Tel. EE. UU. – +1-646-568-7751
USA-Canada Gratuito – +1 800-961-0353
Ventas – [email protected]
